Here we used deep amplicon sequencing to call low allelic fraction STAT3 somatic mutations from the CD8+ cells’ DNA in a larger set of MS cases and controls with much improved sequencing depth compared to our previous studies. The gene discussed is CD8A; the disease is myeloid sarcoma.